Pernix Therapeutics Announces Positive Phase IV Results of Silenor® vs. Zolpidem Head-to-Head Arousability Study
16 juin 2016 08h00 HE
|
Pernix Therapeutics Holdings, Inc.
Data demonstrated that Pernix Therapeutics’ Silenor® 6 mg was superior to zolpidem 10 mg on all measures evaluated. Study results presented at SLEEP 2016 international meeting MORRISTOWN, N.J.,...
Pernix Therapeutics Announces the Issuance of Three New Orange Book Patents for Zohydro® ER with BeadTek™
25 mai 2016 08h00 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., May 25, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that the United States Patent and Trademark...
Pernix Therapeutics Announces CEO Transition
11 mai 2016 08h00 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., May 11, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that Doug Drysdale, after discussions with...
Pernix Therapeutics Overcomes Challenge to Treximet® ‘183 Patent
09 mai 2016 08h00 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that on May 6, 2016, the Patent Trial and...
Pernix Therapeutics to Report First Quarter 2016 Financial Results on Thursday, May 5, 2016
28 avr. 2016 08h30 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., April 28, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it will release financial results for...
Pernix Therapeutics to Present at Needham & Company’s 15th Annual Healthcare Conference
05 avr. 2016 16h01 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., April 05, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman and Chief...
Pernix Therapeutics Files Citizen Petition Following Issuance of U.S. Patent Number 9,265,760 (‘760 Patent) Covering Safety Information Related to Dosing Patients with Zohydro ER® with BeadTek™ CII
02 mars 2016 08h30 HE
|
Pernix Therapeutics Holdings, Inc.
Morristown, NJ, March 02, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced their submission of a Citizen Petition to...
Pernix Therapeutics to Report Fourth Quarter and Full-Year 2015 Financial Results on Thursday, March 10, 2016
24 févr. 2016 08h43 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it will release its fourth quarter and...
Pamlab LLC and Others Seek U.S. International Trade Commission Action to Block Importation of Certain Medical Food Products and Ingredients
12 sept. 2012 11h49 HE
|
Pamlab LLC
WASHINGTON, Sept. 12, 2012 (GLOBE NEWSWIRE) -- Pamlab LLC, a specialty pharmaceutical company that provides medical foods and foods for special dietary use, has joined Merck & Cie and South...